Dosing for adolescent patients (12-17 years)

Adbry is taken every other week after the one-time starter dose

Starting treatment

One-time starter dose:
Starts with two 150 mg prefilled injections (300 mg).

Maintenance dose after starting Adbry:
Then, every other week, one prefilled syringe injection (150 mg).

Step-by-step injection instructions

Watch the video below to learn how to properly inject a full dose of Adbry (tralokinumab-ldrm).

See how to give injections to adolescent patients using prefilled syringes.

See instructions for use

You could pay as little as
$0* for Adbry

Eligible, commercially insured patients may be able to pay a $0* copay for Adbry prescriptions. See Full Terms, Conditions, and Eligibility Criteria.

Get your copay card

*Program has an annual cap. Program may not be combined with any third-party rebate, coupon, or offer.

$0 icon.

Staying on track

Keep up with your treatment routine

Once you learn how to inject Adbry, it’s important to keep up with your routine based on
your healthcare professional’s direction so you can get the most from your treatment.

Getting Adbry

Adbry is a biologic injection that requires special shipping and handling by a specialty pharmacy. This means that your medicine will be shipped to you, rather than having to pick it up in person.

Specialty pharmacies are similar to local pharmacies in a number of ways. The major difference between the two is that a specialty pharmacy manages medicines that require special handling (eg, require refrigeration).

Once you’re prescribed Adbry, someone from the pharmacy will contact you to discuss your insurance coverage and arrange the first shipment. Make sure your prescriber sends the prescription to a specialty pharmacy that is in your insurance network.

Adbry® (tralokinumab-ldrm) syringes package.

Actor portrayal.
Devices shown are not actual size.

Storing Adbry

The proper way to store Adbry® (tralokinumab-ldrm).

Devices shown are not actual size.

Adbry should be stored in the refrigerator between 36°F and 46°F (or 2°C and 8°C).

Don’t freeze Adbry. Don’t use Adbry if it has been previously frozen. 

Like all medicines, Adbry should be kept out of the reach of children.

Helpful materials from the Adbry® Advocate® Program

For details, call 844-MY-ADBRY (844-692-3279) between 8 ᴀᴍ–8 ᴘᴍ EST.
A Case Manager will help you get what you need.

Sharps container, representing safe disposal of Adbry®.

Sharps Container

Safely dispose of your used Adbry autoinjectors or prefilled syringes with a complimentary sharps container. After about 5 to 6 months, mail your full container back and we’ll send you a new one.

Box and envelope representing The Adbry® Welcome Pack of resources.

Welcome Pack

The Adbry Welcome Pack includes an educational brochure, a training demonstration syringe or autoinjector, and a reference guide. Packs offered based on availability. Call 844-MY-ADBRY (844-692-3279) to request.

Travel cold case, representing safe transport of Adbry® during travel.

Travel Cold Case

While you travel, use this case to help safely carry up to 2 Adbry cartons (4 syringes or 2 autoinjectors).

Stay updated on all
things Adbry

Stay informed with
treatment news and tips.

Get updates

Discover tools and resources to
support your journey.

Find support options

Icon of an arrow on a target.

Adbry targets a main cause
of eczema

See how Adbry works

Icon of a magnifying glass.

See what Adbry can do

Explore results

INDICATION

What is ADBRY^® (tralokinumab-ldrm)?

ADBRY^® (tralokinumab-ldrm) injection is a prescription medicine used to treat people 12 years of age and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. ADBRY can be used with or without topical corticosteroids.
It is not known if ADBRY is safe and effective in children under 12 years of age.

Do not use ADBRY if you are allergic to tralokinumab or to any of its ingredients.

Please see full Prescribing Information, including Patient Information and Instructions for Use.

IMPORTANT SAFETY INFORMATION AND INDICATION

IMPORTANT SAFETY INFORMATION

What should I discuss with my healthcare provider before starting ADBRY?

Tell your healthcare provider about all your medical conditions, including if you:

have eye problems.
have a parasitic (helminth) infection.
are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with ADBRY.
are pregnant or plan to become pregnant. It is not known whether ADBRY will harm your unborn baby. There is a pregnancy exposure registry for women who use ADBRY during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. You or your healthcare provider can get information and enroll you in this registry by calling 1-877-311-8972 or visiting https://mothertobaby.org/ongoing-study/adbry-tralokinumab/.
are breastfeeding or plan to breastfeed. It is not known whether ADBRY passes into your breast milk and if it can harm your baby.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I use ADBRY?

See the detailed “Instructions for Use” that comes with ADBRY for information on how to prepare and inject ADBRY and how to properly store and throw away (dispose of) used ADBRY prefilled syringes and autoinjectors.
Use ADBRY exactly as prescribed by your healthcare provider.
Your healthcare provider will tell you how much ADBRY to inject and when to inject it.
ADBRY comes as a single-dose prefilled syringe with needle guard or as an autoinjector.
ADBRY is given as an injection under the skin (subcutaneous injection).
If your healthcare provider decides that you or a caregiver can give the injections of ADBRY, you or your caregiver should receive training on the right way to prepare and inject ADBRY. Do not try to inject ADBRY until you have been shown the right way by your healthcare provider. In children 12 years of age and older, it is recommended that ADBRY be given by or under supervision of an adult.
If you miss a dose, inject the missed dose as soon as possible, then continue with your next dose at your regular scheduled time.
If you inject too much ADBRY than prescribed, call your healthcare provider or call Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.
Your healthcare provider may prescribe other medicines to use with ADBRY. Use the other prescribed medicines exactly as your healthcare provider tells you to.

What are the possible side effects of ADBRY?

ADBRY can cause serious side effects, including:

Allergic reactions (hypersensitivity), including a severe reaction known as anaphylaxis. Stop using ADBRY and tell your healthcare provider or get emergency help right away if you get any of the following symptoms:
- breathing problems
- itching
- skin rash
- swelling of the face, mouth, and tongue
- fainting, dizziness, feeling lightheaded (low blood pressure)
- hives

Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision.

The most common side effects of ADBRY include:

Upper respiratory tract infections
Eye and eyelid inflammation, including redness, swelling, and itching
Injection site reactions
High count of a certain white blood cell (eosinophilia)

These are not all the possible side effects of ADBRY. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read more Collapse